Bank Julius Baer & Co. Ltd, Zurich Cogent Biosciences, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.99 - $9.14 $736 - $1,124	-123 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$7.82 - $9.3 $445 - $530	57 Added 86.36%	123 $1,000
Q1 2021 May 10, 2021	SELL	$7.47 - $12.34 $171 - $283	-23 Reduced 25.84%	66 $1,000
Q4 2020 Feb 24, 2021	BUY	$9.04 - $13.01 $343 - $494	38 Added 74.51%	89 $1,000
Q4 2020 Feb 12, 2021	BUY	$9.04 - $13.01 $461 - $663	51 New	51 $1,000

196

104M

157K

439K

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $366M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.